tiprankstipranks
Chimeric Therapeutics Ceases Over 5 Million Securities
Company Announcements

Chimeric Therapeutics Ceases Over 5 Million Securities

Chimeric Therapeutics Ltd. (AU:CHM) has released an update.

Don't Miss Our Christmas Offers:

Chimeric Therapeutics Ltd. has announced the cessation of 5,816,912 securities due to the lapse of conditional rights. The conditions for these securities were not met, leading to their expiration on December 20, 2024. This development might influence investor perspectives on the company’s stock performance.

For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App